Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models
Development of a protective and broadly-acting vaccine against the most widely distributed human malaria parasite, Plasmodium vivax, will be a major step towards malaria elimination. However, a P. vivax vaccine has remained elusive by the scarcity of pre-clinical models to test protective efficacy a...
Prif Awduron: | Salman, A, Montoya-Díaz, E, West, H, Lall, A, Atcheson, E, Lopez-Camacho, C, Ramesar, J, Bauza, K, Collins, K, Brod, F, Reis, F, Pappas, L, González-Cerón, L, Janse, C, Hill, A, Khan, S, Reyes-Sandoval, A |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Nature Publishing Group
2017
|
Eitemau Tebyg
-
Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors
gan: Atcheson, E, et al.
Cyhoeddwyd: (2018) -
Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
gan: Atcheson, E, et al.
Cyhoeddwyd: (2020) -
A probabilistic model of pre-erythrocytic malaria vaccine combination in mice
gan: Atcheson, E, et al.
Cyhoeddwyd: (2019) -
Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
gan: Alves, E, et al.
Cyhoeddwyd: (2017) -
Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
gan: Bauza, K, et al.
Cyhoeddwyd: (2014)